News about "Piramal Pharma"

Piramal Pharma to Operate its Digwal Facility on Biomass Briquettes to Promote Sustainability

Piramal Pharma to Operate its Digwal Facility on Biomass Briquettes to Promote Sustainability

This achievement marks a substantial step toward Piramal's sustainability goal to reduce Scope 1 and 2 greenhouse gas (GHG) emissions by 42 percent by 2030.

Piramal Pharma | 16/01/2025 | By Aishwarya

Piramal Pharma Gets SBTi Approval for its GHG Emission Reduction Targets

Piramal Pharma Gets SBTi Approval for its GHG Emission Reduction Targets

Piramal Pharma Ltd. has committed to reduce absolute scope 1 and 2 GHG emissions 42 percent by FY2030 from a FY2022 base year.

Piramal Pharma | 17/09/2024 | By Aishwarya 100

Piramal Pharma Gets EIR from US FDA for Bethlehem Plant

Piramal Pharma Gets EIR from US FDA for Bethlehem Plant

The EIR report signifies the closure of the inspection.

Piramal Pharma | 10/11/2023 | By Manvi 468

Piramal Pharma gets EIR from US FDA for Sellersville, USA facility

Piramal Pharma gets EIR from US FDA for Sellersville, USA facility

The inspection has now been successfully closed by the US FDA

Piramal Pharma | 19/04/2023 | By Sudeep Soparkar 534

Piramal Pharma gets EIR for Lexington, Kentucky facility

Piramal Pharma gets EIR for Lexington, Kentucky facility

The inspection has been successfully completed<br />

Piramal Pharma | 20/02/2023 | By Sudeep Soparkar 468

Piramal Pharma's Lexington facility gets six observations from US FDA

Piramal Pharma's Lexington facility gets six observations from US FDA

The observations were classified under VAI (Voluntary Action Indicated) and do not relate to data integrity<br />

Piramal Pharma | 17/01/2023 | By Sudeep Soparkar 229

Piramal Pharma gets zero observations from US FDA for Riverview, Michigan facility

Piramal Pharma gets zero observations from US FDA for Riverview, Michigan facility

The inspection was completed successfully with Zero Form - 483 observations

Piramal Pharma | 11/11/2022 | By Sudeep Soparkar 394

Piramal Pharma Solutions opens API plant in Ontario

Piramal Pharma Solutions opens API plant in Ontario

The new plant, built as part of a CAD 30 million capital investment in the Aurora site, features more than ten thousand square feet of new manufacturing space

Piramal Pharma | 12/07/2022 | By Sudeep Soparkar 525

Piramal Pharma inducts Peter Stevenson, Nathalie Leitch and Sridhar Gorthi to its board

Piramal Pharma inducts Peter Stevenson, Nathalie Leitch and Sridhar Gorthi to its board

The appointments will add to the well-diversified experience that currently exists on the PPL board

Piramal Pharma | 07/07/2022 | By Sudeep Soparkar 476

Piramal Pharma Solutions appoints Herve Berdou as COO

Piramal Pharma Solutions appoints Herve Berdou as COO

Berdou will be based in the Northeastern US

Piramal Pharma's pharma solutions business announced the appointment of Herve Berdou as Chief Operating Officer, Piramal Pharma Solutions (PPS).

Piramal Pharma | 22/06/2022 | By Sudeep Soparkar 265


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members